Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS | |||||||||||||||||||||||||||||||||||||
| May 2016 Volume 17 Number 5 | |||||||||||||||||||||||||||||||||||||
In this issue
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| REVIEWS | Top | ||||||||||||||||||||||||||||||||||||
Translating RNA sequencing into clinical diagnostics: opportunities and challenges Sara A. Byron, Kendall R. Van Keuren-Jensen, David M. Engelthaler, John D. Carpten & David W. Craig p257 | doi:10.1038/nrg.2016.10 RNA sequencing (RNA-seq) is a powerful approach for comprehensive analyses of transcriptomes. This Review describes the widespread potential applications of RNA-seq in clinical medicine, such as detecting disease-associated mutations and gene expression disruptions, as well as characteristic non-coding RNAs, circulating extracellular RNAs or pathogen RNAs. The authors also highlight the challenges in adopting RNA-seq routinely into clinical practice. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Endogenous microRNA sponges: evidence and controversy Daniel W. Thomson & Marcel E. Dinger p272 | doi:10.1038/nrg.2016.20 Empirical evidence supporting the competitive endogenous RNA (ceRNA) hypothesis is accumulating, but studies that model transcriptome-wide binding site abundance suggest that physiological expression changes of most individual transcripts do not compromise microRNA (miRNA) activity. This Review aims to critically evaluate the evidence for and against the ceRNA hypothesis to assess the impact of endogenous miRNA-sponge interactions. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression Andrew P. Feinberg, Michael A. Koldobskiy & Anita Gondor p284 | doi:10.1038/nrg.2016.13 Disruption to the epigenome is increasingly appreciated as a major contributor to the development of cancer. The authors discuss how conceptualizing genes affecting the epigenome as epigenetic modulators, epigenetic modifiers or epigenetic mediators provides a valuable framework for understanding diverse aspects of the causes and consequences of epigenome alteration in cancer. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases Shengdar Q. Tsai & J. Keith Joung p300 | doi:10.1038/nrg.2016.28 Applying CRISPR-Cas9 genome editing technologies in safe and reliable ways requires a firm appreciation of the specificity of target-site recognition and cleavage. In this Review the authors discuss various approaches for characterizing off-target effects of CRISPR-Cas9 genome editing, how mechanistic knowledge can drive the engineering of more-specific nucleases, and the implications for research and therapeutic applications. Abstract | Full Text | PDF | |||||||||||||||||||||||||||||||||||||
| Advertisement | |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||
| *2014 Journal Citation Report (Thomson Reuters, 2015) |
You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount For further technical assistance, please contact our registration department For print subscription enquiries, please contact our subscription department For other enquiries, please contact our feedback department Nature Publishing Group | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |
No comments:
Post a Comment